Thiel W, Preissner K T, Delvos U, Müller-Berghaus G
Blut. 1986 Mar;52(3):169-77. doi: 10.1007/BF00320533.
The important role of protein C (PC) in the regulation of hemostasis has been appreciated since the description of patients who were deficient in PC and presented with severe thromboembolic events. The potentially fatal complications associated with PC-deficiency require an early and reliable identification of those patients affected with this inherited disorder. The present study introduces a test procedure for the functional assessment of PC in plasma samples. The test utilizes the thrombin/thrombomodulin complex to achieve complete and rapid formation of activated PC whose proteolytic capacity is subsequently determined with a chromogenic substrate. Homogenate obtained from rabbit lung effectively substituted the purified component thrombomodulin in the assay system. This new approach simplifies the test procedure without losing specificity and accuracy. Proteases, such as plasmin, streptokinase and urokinase did not influence the assay and the inhibitory effect of heparin on the PC-activation could easily be overcome by the addition of protamine sulphate. The PC-activity in a group of unselected patients (n = 50), who did not reveal any abnormalities in global coagulation tests, amounted to 100 +/- 12% (mean +/- SD) with a range from 54 to 143% when analyzed in comparison to a plasma pool constituted from healthy volunteers. Since the synthesis of PC depends on the availability of vitamin K, patients receiving phenprocoumon have also been analyzed. These patients (n = 103) presented 40 +/- 11% residual PC-activity accompanied by a concomitant decrease in PC-antigen levels to 43 +/- 10% (mean +/- SD). The test described is specific, sensitive, less time-consuming and can be performed on a routine basis.
自描述了蛋白C(PC)缺乏且出现严重血栓栓塞事件的患者以来,人们就认识到了PC在止血调节中的重要作用。与PC缺乏相关的潜在致命并发症需要对受这种遗传性疾病影响的患者进行早期且可靠的识别。本研究介绍了一种用于血浆样本中PC功能评估的测试程序。该测试利用凝血酶/血栓调节蛋白复合物来实现活化PC的完全快速形成,随后用显色底物测定其蛋白水解能力。从兔肺获得的匀浆在测定系统中有效地替代了纯化的血栓调节蛋白成分。这种新方法简化了测试程序,同时又不损失特异性和准确性。诸如纤溶酶、链激酶和尿激酶等蛋白酶不影响该测定,并且通过添加硫酸鱼精蛋白可以轻松克服肝素对PC激活的抑制作用。一组未经挑选的患者(n = 50),其整体凝血测试未显示任何异常,与由健康志愿者组成的血浆池相比,分析时PC活性为100 +/- 12%(平均值 +/- 标准差),范围为54%至143%。由于PC的合成取决于维生素K的可用性,因此也对接受苯丙香豆素治疗的患者进行了分析。这些患者(n = 103)的PC残余活性为40 +/- 11%,同时PC抗原水平相应降低至43 +/- 10%(平均值 +/- 标准差)。所描述的测试具有特异性、敏感性、耗时少,并且可以常规进行。